Cover Image
Market Research Report

United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development)

Published by iGate Research Pvt Ltd Product code 553476
Published Content info 77 Pages
Delivery time: 1-2 business days
Price
Back to Top
United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development)
Published: August 9, 2017 Content info: 77 Pages
Description

The United States market for pain management therapeutics remains a substantial growth area for pharmaceutical companies, as they continue their efforts to maintain significant growth margins by tapping into markets of major unmet medical needs. United States Pain Therapeutics market persists with regular developments and discoveries of new drugs addressing pain related health ailment issue. The widespread availability of drugs and the advent of new drugs have accelerated the pace of growth in the market.

The pain management market is fueled by the segments like arthritis pain, cancer pain, back pain, fibromyalgia, migraine pain, neuropathic pain and post-operative pain relief markets. The largest segment of the United States pain management market is the arthritis while pediatric pain is the smallest segment for the pain management. The cancer pain management market is the most rapidly growing segment of the United States pain management market.

iGATE Research report titled “United States Pain Management Therapeutics Market, Patients Volume, and 50 Company's Pipeline Analysis (By Product, Indication, Phase of Development)” provides a comprehensive assessment of the fast-evolving, high-growth of United States Pain Management Therapeutics Sector.

This 77 Page report with 45 Figures and 3 Tables studies in details:

  • I. United States Pain Management Therapeutics Market and Forecast (2007 - 2022)
  • II. United States Pain Management Patients Volume and Forecast (2007 - 2022)
  • III. 50 Company's Pipeline Product Analysis (By Product, Indication, Phase of Development)
  • IV. United States Pain Management Therapeutics Market - Driving Factors & Challenges

10 Pain Management Segments covered in the report are as follows:

  • 1. Arthritis Pain
  • 2. Migraine Pain
  • 3. Post-Operative Pain
  • 4. Cancer Pain
  • 5. Neuropathic Pain
  • 6. Back Pain
  • 7. Fibromyalgia Pain
  • 8. Facial Pain
  • 9. Pediatric Pain
  • 10. Obstetrical Pain

Company Wise Pipeline Analysis (By Product, Indication, Phase of Development) - 50 Companies Covered

  • 1. Teva Pharmaceutical
  • 2. Astellas Pharmaceuticals Inc.
  • 3. Durect Corporation
  • 4. Pfizer
  • 5. AbbVie Inc.
  • 6. AcelRx Pharmaceuticals, Inc.
  • 7. Acorda Therapeutics Inc.
  • 8. Achelios Therapeutics
  • 9. Alder BioPharmaceuticals Inc.
  • 10. Allergan
  • 11. Amgen Inc.
  • 12. AstraZeneca/MedImmune
  • 13. Avanir Pharmaceuticals Inc.
  • 14. Axsome Therapeutics, Inc
  • 15. BioDelivery Sciences International
  • 16. Cara Therapeutics
  • 17. COLLEGIUM Pharmaceutical Inc.
  • 18. Centrexion Therapeutics
  • 19. Daiichi Sankyo Company Ltd.
  • 20. Depomed Inc.
  • 21. Egalet Corporation
  • 22. Eli Lilly and Company
  • 23. Endo Pharmaceuticals Inc.
  • 24. EpiCept
  • 25. FemmePharma
  • 26. Flexion Therapeutics Inc.
  • 27. Galapagos NV
  • 28. Heron Therapeutics
  • 29. Helsinn Healthcare SA
  • 30. INSYS THERAPEUTICS, INC
  • 31. Iroko Pharmaceuticals
  • 32. KemPharm, Inc
  • 33. Mesoblast Ltd
  • 34. Novartis International AG
  • 35. Nuvo Pharmaceuticals
  • 36. Nektar Therapeutics
  • 37. NeurAxon
  • 38. Newron Pharmaceuticals
  • 39. Olatec Industries
  • 40. Otsuka Pharmaceutical
  • 41. PLx Pharma
  • 42. Orexo AB
  • 43. Regeneron Pharmaceuticals Inc.
  • 44. Recro Pharma, Inc
  • 45. Relmada Therapeutics, Inc
  • 46. Scintilla Pharmaceuticals, Inc.
  • 47. Trevena Inc.
  • 48. Trigemina, Inc.
  • 49. WEX Phamaceuticals Inc
  • 50. Zynerba Pharmaceuticals, Inc.

Data Sources:

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies:

  • Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
  • Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Table of Contents

Table of Contents

1. Executive Summary

2. United States-Pain Management Therapeutics Market

3. United States-Pain Management Patient Population

4. United States-Pain Management Therapeutics Market Share

5. United States-Segment Wise Pain Management Therapeutics Market & Population

  • 5.1. United States-Arthritis Pain Management Therapeutics Analysis (2007-2022)
    • 5.1.1. United States-Arthritis Pain Management Therapeutics Market & Forecast
    • 5.1.2. United States-Arthritis Pain Management Therapeutics Population & Forecast
  • 5.2. United States-Migraine Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.2.1. United States-Migraine Pain Management Therapeutics Market & Forecast
    • 5.2.2. United States-Migraine Pain Management Patient Population & Forecast
  • 5.3. United States-Post Operative Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.3.1. United States-Post Operative Pain Management Therapeutics Market & Forecast
    • 5.3.2. United States-Post Operative Pain Management Patient Population & Forecast
  • 5.4. United States-Cancer Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.4.1. United States-Cancer Pain Management Therapeutics Market & Forecast
    • 5.4.2. United States-Cancer Pain Management Patient Population & Forecast
  • 5.5. United States-Neuropathic Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.5.1. United States-Neuropathic Pain Management Therapeutics Market & Forecast
    • 5.5.2. United States-Neuropathic Pain Management Patient Population & Forecast
  • 5.6. United States-Back Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.6.1. United States-Back Pain Management Therapeutics Market & Forecast
    • 5.6.2. United States-Back Pain Management Patient Population & Forecast
  • 5.7. United States-Fibromyalgia Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.7.1. United States-Fibromyalgia Pain Management Therapeutics Market & Forecast
    • 5.7.2. United States-Fibromyalgia Pain Management Patient Population & Forecast
  • 5.8. United States-Facial Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.8.1. United States-Facial Pain Management Therapeutics Market & Forecast
    • 5.8.2. United States-Facial Pain Management Patient Population & Forecast
  • 5.9. United States-Pediatric Pain Management Therapeutics Market, Population & Forecast (2007-2022)
    • 5.9.1. United States-Pediatric Pain Management Therapeutics Market & Forecast
    • 5.9.2. United States-Pediatric Pain Management Patient Population & Forecast
  • 5.10. United States-Obstetrical Pain Management Therapeutics Market, Population & Forecast (2005-2018)
    • 5.10.1. United States-Obstetrical Pain Management Therapeutics Market & Forecast

6. Pain Management Therapeutics Pipeline Products-By Company, Indication, Phase of Development

7. United States Pain Management Therapeutics Market-Driving Factors

  • 7.1. Elderly Population
  • 7.2. Unmet Need but Strong Pipeline Products

8. United States Pain Management Therapeutics Market-Challenges

  • 8.1. Pain Medications, Particularly Opioids, are Associated with Several Side Effects
  • 8.2. Difficulty in Pain Diagnosis Leads to Low Prescription Rates
  • 8.3. Availability of Generics

List of Figures

  • Figure 2-1: United States-Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 2-2: United States-Forecast for Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 3-1: United States-Pain Management Patient Population (Million), 2007-2016
  • Figure 3-2: United States-Forecast for Pain Management Patient Population (Million), 2017-2022
  • Figure 5-1: United States-Arthritis Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-2: United States-Forecast for Arthritis Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-3: United States-Arthritis Pain Management Patient Population (Million), 2007-2016
  • Figure 5-4: United States-Forecast for Arthritis Pain Management Patient Population (Million), 2017-2022
  • Figure 5-5: United States-Migraine Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-6: United States-Forecast for Migraine Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-7: United States-Migraine Pain Management Patient Population (Million), 2007-2016
  • Figure 5-8: United States-Forecast for Migraine Pain Management Patient Population (Million), 2017-2022
  • Figure 5-9: United States-Post Operative Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-10: United States-Forecast for Post Operative Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-11: United States-Post Operative Pain Management Patient Population (Million), 2007-2016
  • Figure 5-12: United States-Forecast for Post Operative Pain Management Patient Population (Million), 2017-2022
  • Figure 5-13: United States-Cancer Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-14: United States-Forecast for Cancer Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-15: United States-Cancer Pain Management Patient Population (Million), 2007-2016
  • Figure 5-16: United States-Forecast for Cancer Pain Management Patient Population (Million), 2017-2022
  • Figure 5-17: United States-Neuropathic Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-18: United States-Forecast for Neuropathic Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-19: United States-Neuropathic Pain Management Patient Population (Million), 2007-2016
  • Figure 5-20: United States-Forecast for Neuropathic Pain Management Patient Population (Million), 2017-2022
  • Figure 5-21: United States-Back Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-22: United States-Forecast for Back Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-23: United States-Back Pain Management Patient Population (Million), 2007-2016
  • Figure 5-24: United States-Forecast for Back Pain Management Patient Population (Million), 2017-2022
  • Figure 5-25: United States-Fibromyalgia Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-26: United States-Forecast for Fibromyalgia Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-27: United States-Fibromyalgia Pain Management Patient Population (Million), 2007-2016
  • Figure 5-28: United States-Forecast for Fibromyalgia Pain Management Patient Population (Million), 2017-2022
  • Figure 5-29: United States-Facial Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-30: United States-Forecast for Facial Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-31: United States-Facial Pain Management Patient Population (Million), 2007-2016
  • Figure 5-32: United States-Forecast for Facial Pain Management Patient Population (Million), 2017-2022
  • Figure 5-33: United States-Pediatric Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-34: United States-Forecast for Pediatric Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 5-35: United States-Pediatric Pain Management Patient Population (Number), 2007-2016
  • Figure 5-36: United States-Forecast for Pediatric Pain Management Patient Population (Number), 2017-2022
  • Figure 5-37: United States-Obstetrical Pain Management Therapeutics Market (Million US$), 2007-2016
  • Figure 5-38: United States-Forecast for Obstetrical Pain Management Therapeutics Market (Million US$), 2017-2022
  • Figure 7-1: United States-Elderly Population 60 Years and Above (Million), 2007-2016
  • Figure 7-2: United States-Forecast for Elderly Population 60 Years and Above (Million), 2017-2022
  • Figure 7-3: Pain Management Therapeutics-Number of Pipeline Candidate in Development Phase

List of Tables

  • Table 4-1: United States-Pain Management Therapeutics Market Share (Percent), 2007-2016
  • Table 4-2: United States-Forecast for Pain Management Therapeutics Market Share (Percent), 2017-2022
  • Table 6-1: Pain Management Therapeutics-List of pipeline Products (By Company, Indication, Phase of Development), July 2017
Back to Top